About: Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $1.31 (-0.76%)
CRDL NASDAQ Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc Class A share price
CRDL price activity
Last Price
$1.320
Change (24hr)
-0.01 USD (-0.38%)
Volume
363.06K
Volume (4w avg)
-
Open
$1.31
Day Range
$1.26 - $1.34
Previous Close
$1.32
Last Trade
08 Oct, 4:20 pm GMT+0
Delayed
08 Oct, 4:20 pm GMT+0
CRDL price performance
Delayed
08 Oct, 4:20 pm GMT+0
CRDL Market Signals